In a rare exception to long-standing American foreign policy, U.S.
officials have approved a small California biotech company's deal
with the Cuban government to develop three experimental cancer drugs
created in Havana. The agreement announced Thursday by CancerVax Corp.
is the first such commercial deal approved by the U.S. government
between a U.S. biotechnology company and Cuba, which has spent $1
billion building a biotechnology program that is among the most
advanced in the Third World. [more]
Article originally appeared on (http://brownwatch.com/).
See website for complete article licensing information.